Good morning and welcome back to your am edition of the Democratic Wins Media newsletter. There’s a thread running through all three stories this morning, and it’s about who actually does things. Trump’s advisers are telling reporters the electoral map is slipping. A Republican senator went on television and called the president’s vaccine order what it is: crazy. And the president held up a newspaper headline about falling drug prices without reading the part of the article explaining which law caused it. In every case, the work was done by somebody else — and in two of the three, that somebody was a Democrat.
Here’s what we’re covering:
Trump’s advisers privately admit the GOP’s grip on Congress is slipping — and the money tells a more complicated story.
A Republican doctor in the Senate calls Trump’s vaccine order “crazy, stupid” as Democratic AGs fight it in court.
Drug prices just posted their steepest drop since 1963. The experts point to the law every Republican voted against.
Before the news, a word about why this newsletter exists. The Ellison family now controls CBS News and CNN with Bari Weiss in charge. Bezos owns the Washington Post. Murdoch runs Fox and Roku. The billionaires are buying every outlet that could hold them accountable. Democratic Wins Media is the alternative: we’re fully reader-funded, editorially independent, and will never be purchased. If you have been reading on a free subscription, this morning is the moment to upgrade to a paying membership. Subscribe or upgrade right now.
CNN reported Saturday that Trump has finally greenlit millions from his personal PAC to prop up vulnerable Republicans, with one person familiar with the discussions floating $30 million in a first tranche and another cautioning that no figure is settled. The reason for the sudden urgency, according to the reporting: top campaign advisers privately concede that Republicans’ chances of holding both the House and Senate are dwindling. Aides also told CNN the president doesn’t much enjoy campaigning for anyone but himself. “He loves to travel, but he hates to travel,” one said. Advisers say his enthusiasm for the midterm push could evaporate as fast as it appeared. The White House says Trump is committed to protecting the Republican majority.
Now the part that should keep us honest. Trump’s MAGA Inc. reported more than $400 million in cash reserves as of late July, the largest war chest in the country. The Senate Leadership Fund has committed $342 million across battlegrounds. And the Supreme Court recently struck down limits on what party committees can spend in coordination with individual candidates — a ruling Republican operatives openly say helps them most, because they hold more money in PACs and outside groups than Democrats do.
You can see both realities in one race. Trump was on Long Island Friday for Bruce Blakeman, his pick against Gov. Kathy Hochul. A Siena College poll of 811 likely New York voters, conducted August 3–6 with a margin of error of ±4.2 points, put Hochul ahead 49–39. That’s a real lead. It’s also down from a 20-point margin among registered voters in June, and Hochul is under 50 percent. She leads on affordability, 48–41. She trails Blakeman among independents. Blakeman disputes the poll.
Why it matters: A demoralized opponent with $400 million is still an opponent with $400 million. The reporting out of Trump’s own operation is real evidence that the environment favors Democrats right now — and the environment is not a turnout operation, a field program, or a check. Hochul’s lead is the kind you win with and the kind you lose by six, which is exactly what happened to her in 2022. Three months is enough time for this to break either way.
By the numbers: $400 million in Trump’s MAGA Inc. war chest as of late July.
On August 10, Trump signed an executive order directing that the combined measles, mumps and rubella vaccine be split into three separate single-disease shots once such products exist domestically, and that childhood immunizations be given at separate visits wherever feasible. The order cuts the list of diseases all children are advised to be immunized against from 18 to 11, moving the rest to high-risk-only or case-by-case categories. It also instructs the attorney general to pursue litigation against states that don’t offer religious and medical exemptions to school vaccine requirements. Signing it, Trump said the combined shot might be “quite lethal” — a claim decades of evidence contradict, and one he later acknowledged he could not support. Separate measles, mumps and rubella vaccines are not currently available in the US; manufacturers would need new clinical trials and approvals.
Sen. Bill Cassidy (R-La.) — a physician who chairs the Senate Health, Education, Labor and Pensions Committee, and who cast the deciding vote to confirm Robert F. Kennedy Jr. after Kennedy pledged not to alter the childhood schedule — took it apart on CNN’s State of the Union Sunday. Two doctor visits become six, he said. Two shots become six. Parents miss work six times instead of twice. Insurers pay for six visits instead of two, which flows into premiums. And it does nothing for autism. Asked directly whether the president was saying crazy, stupid things about vaccines, Cassidy said yes: “That’s a crazy, stupid thing!” He had already posted on August 10 that parents should listen to their pediatrician instead of the order — “This is so wrong.”
The medical establishment is unanimous. The American Academy of Pediatrics called the order “not only disheartening but dangerous,” noting measles cases have hit their highest level since 1991. The American Medical Association said it puts children’s health at risk. A study of 2.5 million American children found no association between MMR timing before age two and later autism diagnosis.
The four states the order targets for DOJ litigation — California, Connecticut, Maine and New York — have among the nation’s highest immunization rates and have been among the most successful at containing the outbreak. Maine Gov. Janet Mills said her state isn’t budging: “Maine will continue to follow the science and the facts.” And this is already in court. In February, California AG Rob Bonta and Arizona AG Kris Mayes co-led a 15-state suit, joined by Pennsylvania Gov. Josh Shapiro, challenging the CDC decision memo that stripped seven childhood vaccines of universal recommendation status and challenging Kennedy’s replacement of the federal vaccine advisory panel. Courts have already frozen parts of the administration’s earlier effort.
Why it matters: Cassidy’s framing is the one to steal, because it isn’t ideological — it’s arithmetic. Six visits instead of two is lost wages, higher premiums, and more sick kids, and he made the affordability argument against the president more cleanly than most Democrats have. Meanwhile Democratic attorneys general and governors aren’t waiting for the Senate to grow a spine; they filed in February and they’re winning delays. That’s the division of labor that actually works: Republicans supply the credibility, Democrats supply the injunction.
Prescription drug prices fell 3.1 percent in the year ending in July — the steepest annual decline since March 1963, according to Bureau of Labor Statistics data released last week. The broader medicinal drug category, which includes over-the-counter medications, fell 2.7 percent, the largest annual drop on record.
Trump noticed. On Friday, walking to Air Force One at Joint Base Andrews, he waved a printout of the Washington Post headline at the press pool and asked, “is anybody impressed?” On Saturday the White House posted the photo with the caption: “POV: you bring the receipts.” Communications director Steven Cheung credited Most-Favored-Nation pricing and TrumpRx.
The trouble is the article. Three paragraphs into the piece Trump was holding, the Post reports that while the White House claimed credit, some experts said a Biden-era policy requiring Medicare to negotiate prices “is more likely to be driving down costs.” Richard Frank, a Brookings senior fellow and emeritus Harvard health economist, told the Post that if he were betting on what mattered most, he’d put it on the Inflation Reduction Act. The Post credits several factors — more generics on the market and cheaper GLP-1 weight-loss drugs among them — but Medicare negotiation is the one its experts kept returning to.
Here’s the timeline. Democrats passed the IRA in 2022 with no Republican votes, giving Medicare authority to negotiate drug prices for the first time in the program’s history. CMS announced the first ten negotiated prices in August 2024 — discounts of 38 to 79 percent off list prices. Those prices took effect January 1 of this year. CMS estimated the deal would have saved Medicare roughly $6 billion had it been in place in 2023, and projects about $1.5 billion in out-of-pocket savings for the roughly nine million enrollees who use those drugs. Fifteen more drugs, including Ozempic and Wegovy, are negotiated and take effect in 2027.
One caveat worth keeping: overall consumer prices still rose 3.4 percent over the same period. Drug prices are one of the few bright spots in that report, not evidence the cost-of-living squeeze has lifted.
Why it matters: This is the whole argument in one photograph. Democrats spent a decade being told that taking on the pharmaceutical industry was naive, passed the law without a single Republican vote, waited four years for the prices to take effect — and the result is the biggest drop in prescription drug prices since 1963, now being waved around by a president whose party voted against it. Policy has a lag. That’s precisely why it’s worth voting for people who write it, and why the credit for what’s working right now belongs to a Congress that has been out of power for two years.
By the numbers: 38 to 79 percent — the discounts CMS negotiated off list prices for the first ten drugs.
Their advisers are conceding the map, their own senators are calling the president’s health policy dangerous nonsense, and the one economic number he’s proud enough to wave at reporters was produced by a law every Republican in Congress voted against — the case for Democrats this morning isn’t that the other side is failing, it’s that ours has already shown its work.
Here’s the highest-leverage thing you can do this morning: become a paying subscriber. Republican advisers privately conceding they may lose Congress while sitting on a $400 million war chest, a Republican physician calling the president’s childhood vaccine order dangerous nonsense while Democratic attorneys general fight it in court, and the sharpest drop in drug prices since 1963 traced back to a law Democrats passed alone — these are the stories that get flattened into “both sides are mad” when a newsroom answers to an owner with business before this administration. Democratic Wins Media doesn’t have one. We answer to readers, which is the only reason we can tell you when the news is good and still tell you not to relax. We’re running way behind on our August paid subscribers goal. Every upgrade goes directly into funding the reporting you just read. Upgrade now →
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.